AEON Trademark

Trademark Overview

On Monday, September 23, 2019, a trademark application was filed for AEON with the United States Patent and Trademark Office. The USPTO has given the AEON trademark a serial number of 88626890. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, December 12, 2025. This trademark is owned by AEON Biopharma, Inc.. The AEON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological conditions; Pharmaceutical preparations for the treatment of gastrointestinal conditions; Pharmaceutical preparations for the treatment of neurologic and psychiatric disorders; botulinum toxins for therapeutic use
aeon

General Information

Serial Number88626890
Word MarkAEON
Filing DateMonday, September 23, 2019
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, December 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 6, 2025

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a stylized letter "A" placed to the left of the term "AEON".
Goods and ServicesPharmaceutical preparations for the treatment of neurological conditions; Pharmaceutical preparations for the treatment of gastrointestinal conditions; Pharmaceutical preparations for the treatment of neurologic and psychiatric disorders; botulinum toxins for therapeutic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAEON Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614
Party NameAEON Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Trademark Events

Event DateEvent Description
Thursday, September 26, 2019NEW APPLICATION ENTERED
Friday, September 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 28, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 23, 2019ASSIGNED TO EXAMINER
Tuesday, December 31, 2019NON-FINAL ACTION WRITTEN
Tuesday, December 31, 2019NON-FINAL ACTION E-MAILED
Tuesday, December 31, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 18, 2020SUSPENSION LETTER WRITTEN
Saturday, July 18, 2020LETTER OF SUSPENSION E-MAILED
Saturday, July 18, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 1, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 3, 2022ASSIGNED TO EXAMINER
Tuesday, January 18, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 22, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 1, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, March 28, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 28, 2023NON-FINAL ACTION E-MAILED
Tuesday, March 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 5, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 31, 2023SUSPENSION LETTER WRITTEN
Monday, July 31, 2023LETTER OF SUSPENSION E-MAILED
Monday, July 31, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 9, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, February 27, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, January 16, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, April 3, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 30, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 6, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 6, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 1, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 12, 2025SOU TEAS EXTENSION RECEIVED
Friday, December 12, 2025SOU EXTENSION 1 FILED
Friday, December 12, 2025SOU EXTENSION 1 GRANTED
Saturday, December 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

aeon pharmaceutical treatment preparations conditions botulinum toxins therapeutic disorders gastrointestinal neurological